No profile data available.
Cumberland Pharmaceuticals Inc. (CPIX) is a healthcare company in the digestive system treatment drugs industry, based in Nashville, United States, with about 88 full-time employees.
It reported revenue of $37.87 million for fiscal year 2024, down 4.3% from fiscal year 2023, and net income of -$6.48 million. In Q3 2025 (the quarter ended September 30, 2025) revenue was $8.29 million, down 8.7% from a year before. United States was its largest region in fiscal year 2025, with 89% of revenue. Its market capitalization was $105.33 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
, a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products.
Cumberland Pharmaceuticals reported $37.87 million in revenue for fiscal year 2024, down 4.3% from $39.55 million in fiscal year 2023. In Q3 2025 revenue was $8.29 million.
United States: 89% of revenue by region in fiscal year 2025, followed by China (7%).
$105.33 million as of October 9, 2026.
Listed companies of a similar size in the same industry (digestive system treatment drugs) include Ironwood Pharmaceuticals, Inc. (IRWD), Phathom Pharmaceuticals, Inc. (PHAT), Palisade Bio, Inc. (PALI), Heron Therapeutics, Inc. (HRTX).